Inflammatory gene expression following genotoxic cancer therapy is well documented, yet the events underlying its induction remain poorly understood. Inflammatory cytokines modify the tumour microenvironment by recruiting immune cells and are critical for both local and systemic (abscopal) tumour responses to radiotherapy 1 . A poorly understood feature of these responses is the delayed onset (days), in contrast to the acute DNA-damage responses that occur in minutes to hours. Such dichotomous kinetics implicate additional rate-limiting steps that are essential for DNA-damageinduced inflammation. Here we show that cell cycle progression through mitosis following double-stranded DNA breaks leads to the formation of micronuclei, which precede activation of inflammatory signalling and are a repository for the pattern-recognition receptor cyclic GMP-AMP synthase (cGAS). Inhibiting progression through mitosis or loss of pattern recognition by stimulator of interferon genes (STING)-cGAS impaired interferon signalling. Moreover, STING loss prevented the regression of abscopal tumours in the context of ionizing radiation and immune checkpoint blockade in vivo. These findings implicate temporal modulation of the cell cycle as an important consideration in the context of therapeutic strategies that combine genotoxic agents with immune checkpoint blockade.
DSB-induced STAT1 activation correlated with the appearance of aberrantly shaped nuclei and micronuclei (Figs 1f, 2a ). The DSB marker γ H2AX was increased in micronuclei, however, 53BP1 was absent, consistent with DSB signalling defects 5, 6 (Fig. 1f ). Nuclei of NHEJ-knockout and DNA-PKi-treated cells were morphologically normal despite being replete with DSBs (Figs 1f, 2a ). As micronuclei are by-products of mitotic progression, this suggested that STAT1 activation occurred following mitosis 7 . Flow cytometry showed progression from G2 into G1 between 24 and 48 h after ionizing radiation, whereas NHEJ-knockouts were static over this time (Extended Data Fig. 2a ). This corresponds to a wave of parental cells moving into mitosis as evidenced by phosphorylated histone H3 (pH3) staining that is absent in the NHEJ-knockout cells (Fig. 2b) . Notably, the specific CDK1 inhibitor RO-3306 (CDK1i) or PLK1 inhibitor BI-2536 (PLK1i) blocked mitotic entry, micronuclei formation and STAT1 activation (Figs 2a-c, Extended Data Fig. 2b ). Furthermore inhibition of cell cycle progression by other CDKi reduced the flux of cells through mitosis and STAT1 activation (Extended Data Fig. 2c, d ). CDK1i also prevented STAT1 activation in PARPi-treated BRCA1-mutated ovarian cancer cells ( Fig. 2d ), suggesting that mitotic entry is a gateway to inflammatory signalling for diverse DSB-inducing stimuli. To further test the requirement for mitotic progression, we synchronized cells in G2 before irradiation. Release from CDK1i after ionizing radiation resulted in progression from G2 into the following G1 over 72 h as determined by loss of the S/G2-phase and mitosis marker CENP-F ( Fig. 2e ). STAT1 phosphorylation levels were greater than those observed in asynchronous cells and absent in cells not released from G2 (Fig. 2f ). STAT1 phosphorylation can be elicited following activation of the DNA-dependent pattern recognition receptor cGAS and its downstream mediators STING and IRF3, which serve to transcriptionally activate type I interferon [8] [9] [10] [11] [12] [13] [14] [15] [16] . CRISPR-Cas9 knockout of either cytosolic cGAS or STING reduced activation of downstream IRF3 target genes ISG54, ISG56 and the NF-κ B target CCL5 after ionizing radiation 17, 18 ( Fig. 3a , Extended Data Fig. 3a ). Attenuated STAT1 activation and IFITM1 induction was also evident in cGAS-STING knockouts (Fig. 3b , Extended Data Fig. 3b ). Senescence-associated β -galatosidase staining was relatively unaffected by treatments that influence inflammatory activation (Extended Data Fig. 3c ), suggesting that alterations in epithelial cell senescence were not contributory to the reduced interferon signalling observed upon inhibiting mitotic entry or pattern recognition receptor activation.
cGAS localization was prominent in lamin-B2-positive micronuclei of CENP-F-negative (G1) cells three days following ionizing radiation ( Fig. 3c, d , Extended Data Fig. 3d, e ). Synchronized cells showed cGAS localization to micronuclei concomitant with mitotic passage, G1 accumulation and STAT1 activation ( Fig. 2e , f, Extended Data Fig. 4a ). Delayed accumulation of mCherry-cGAS in micronuclei was also observed (Extended Data Fig. 4b ) and live-cell microscopy showed dynamic and persistent relocalization of cGAS to micronuclei following mitosis ( Fig. 3e , Supplementary Video 1). Interestingly, cGAS localized to bulk chromatin during mitosis, but dissociated at completion of mitosis. cGAS concentrated in the micronuclei after a transient delay, consistent with reported changes in permeability owing to delayed micronuclear envelope rupture 19 . Live-cell imaging revealed that around 20% of daughter cells were undergoing rapid post-mitotic apoptosis (Supplementary Video 2). The remaining 80% of daughter cells all contained micronuclei, the majority of which showed strong and persistent cGAS concentration (Extended Data Fig. 4c ).
The preceding data support a model whereby loss of micronuclear envelope integrity can provide access to damaged DNA. When MCF10A cells were subjected to migration through 3-μ m pores, we observed cGAS localization to both micronuclei and nuclear blebs consistent with nuclear envelop disruption and transient DSB production 20 (Extended Data Fig. 4d, e ). cGAS positivity of these subcellular .289 or UWB1.289+ BRCA1 reconstituted cells treated for 6 days with PARPi treatment with or without CDK1i (n = 3 biological replicates). e, Cells were synchronized in G2 with CDK1i before irradiation and released for the indicated times. CENP-F positive (S/G2), CENP-F negative (G0/G1) and mitotic cells were quantified for three independent biological replicates. Error bars represent s.e.m. f, Representative western blot for STAT1 activation following the release scheme described in e (n = 3 biological replicates). AS, asynchronous; Unrel., unreleased.
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structures still occurred in the presence of CDKi, demonstrating that mechanical nuclear rupture bypasses the need for mitotic progression. Furthermore, micronuclei generated using Aurora B kinase inhibition were cGAS-positive and elicited robust STAT1 activation without irradiation (Extended Data Fig. 4f , g).
Micronuclei harbouring accumulated cGAS may act to initiate inflammatory signalling. RNA fluorescent in situ hybridization (FISH) revealed coincident expression of interferon-stimulated gene ISG54 specifically in cells containing micronuclei (P ≤ 0.001 at 6 days after 20 Gy by paired t-test; Fig. 3f ). This effect was abrogated by knockout of cGAS, STING, or XRCC4, and by CDK1i. In an independent test of this association, expression of an IFNB1 promoter controlled eGFP transgene increased specifically in micronucleated cells at 6 days following 10 Gy (P ≤ 0.01 by 1-way ANOVA; Extended Data Fig. 5a ). These findings firmly establish an important relationship between the presence of micronuclei and inflammatory signalling. We cannot ascribe the inflammatory response solely to micronuclei as small DNA fragments in the cytoplasm could also contribute to cGAS-STING activation 10, 21 . However, our data show robust relocali zation of cGAS to the micronucleus and activation of inflammatory responses within these micronucleated cells.
Only subtle induction of nuclear phosphorylated IRF3 (pIRF3) was detected by immunofluorescence in damaged cells (Extended Data Fig. 5b ). This suggests that chronic DNA-damage-induced inflammatory activation emanating from cGAS-positive micronuclei may differ in magnitude from the acute signalling that occurs within hours following transfection of microgram quantities of exogenous DNA (Extended Data Fig. 5c ). To determine whether paracrine signals could amplify cGAS-STING-mediated signalling, we transferred media from irradiated cells to naive parental cells and assayed for STAT1 activation (Fig. 3g) . These experiments reveal ionizing radiation induced paracrine signalling that required mitotic progression and cGAS-STING. Several case reports have described an abscopal effect defined as tumour regression outside of the irradiated field. This is most often observed in combination with immune checkpoint blockade (that is, anti-CTLA4 antibody) [22] [23] [24] , suggesting that local radiation can be immunomodulatory. We have extensively characterized how irradiation of one tumour along with immune checkpoint blockade can produce T-cell-dependent responses in the contralateral unirradiated tumour using the B16 syngeneic mouse model of melanoma 24, 25 . To examine the dependence of abscopal responses on the cGAS-STING pathway, we used this B16 model and irradiated cells ex vivo (Fig. 4a ). Irradiation of B16 melanoma cells before injection caused significant reduction in the growth of abscopal tumours after anti-CTLA4 treatment (Fig. 4b) .
In contrast, implanting irradiated B16 cells harbouring STING deletion eliminated the radiation-mediated growth delay of the abscopal tumour after anti-CTLA4 ( Fig. 4b , Extended Data Fig. 6a, b) . Radiation in the absence of anti-CTLA4 was insufficient to induce the abscopal effect (Extended Data Fig. 6c ). The abscopal tumour volume reduction as measured at day 15 was not observed when the implanted cells were STING deficient ( Fig. 4c ). Loss of STING in the irradiated tumour also significantly reduced overall survival in the mice (Extended Data Fig. 6d ). A similar effect on tumour size with STING loss was noted in abscopal tumours when the contralateral tumour was irradiated directly in the mice (Extended Data Fig. 6e , f). Consistent with a requirement for T cell responses, STING knockout prevented the enrichment of intratumoral CD8 T cells in the abscopal tumour 24, 26 (Fig. 4d ). Thus, STING signalling is a critical component of host immune activation that drives regression of distal tumours in radiotherapy and anti-CTLA4 combination therapy.
Checkpoint adaptation and insensitivity has been described in a wide range of eukaryotic organisms 27, 28 . Our data support a model in which imperfect cell cycle checkpoints allow passage through mitosis and accumulation of micronuclei where pattern recognition occurs (Fig. 4e ). This represents a situation in which actively cycling cells contribute to delayed onset inflammatory signalling in the context of DSBinducing therapies. These findings suggest possibilities to modulate the host immune system and ultimately the success of genotoxic therapies.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
Letter reSeArCH MethOdS Data reporting. No statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. Cell lines and tissue culture. MCF10A cells were obtained from ATCC, stably transfected to express Cas9 as described below, and cultured in a 1:1 mixture of F12:DMEM media with 5% horse serum (Thermo Fisher Scientific), 20 ng ml −1 human EGF (Peprotech), 0.5 mg ml −1 hydrocortisone, 100 ng ml −1 cholera toxin and 10 μ g ml −1 recombinant human insulin (Sigma). MCF10A-IPpoI cells were previously described 29 and U2OS-IPpoI and MCF10A-AsiSI cells were prepared with identical procedures. The AsiSI cDNA was a gift from New England Biolabs and was cloned by PCR into the pLVX-PTuner vector (Clontech) with an oestrogen receptor tag derived by PCR from the pLVX-PTuner-IPpoI vector. B16-F10 and U2OS cells were purchased from ATCC and cultured in DMEM with 10% FBS. UWB1.289 and UWB1.289+ BRCA1 cells were obtained from ATCC and cultured in a 1:1 mixture of RPMI1640 and MEGM (prepared from BulletKit, Lonza) with 10% FBS added. All cells were cultured in the presence of penicillin and streptomycin (Thermo Fisher Scientific). Normal Prostate Epithelial Cells (PREC) were purchased from Lonza and cultured according to recommended protocols. Cell lines were not authenticated futher and were verified as mycoplasma free (Lonza). Irradiation and cell treatments. All cells were seeded such that they reached no greater than 60-70% confluence at the time of treatment. Media was changed every 2-3 days after treatment. Irradiation was performed under ambient oxygen using a Cs-137 Gammacell irradiator (Nordion) at a dose rate of ~ 0.8 Gy min −1 . Inhibitors were added 1 h before treatment and maintained until collection unless otherwise noted: DNA-PKi (NU-7441, 2 μ M, Tocris), CDK1i (RO-3306, 9 μ M, Tocris), ruxolitinib (1 μ M, Cayman Chemicals), PLK1i (BI-2536, 10 nM, Selleck Chemicals), Aurora Bi (AZD1152-HQPA, 10 nM, Selleck Chemicals), CDK1/2/4i (R547, 0.6 μ M, Cayman Chemicals), CDK4/6i 1 (PD332991, 1 μ M, Cayman Chemicals), CDK4/6i 2 (LY28352169, 2.5 μ M, Cayman Chemicals) and ATMi (Ku55933, 10 μ M, Selleck Chemicals). PARPi (AZD-2281, 5 μ M, LC Laboratories) was added to UWB1.289 cells and kept on for the duration of the 6 days before collection. IFNβ 1 (Peprotech) was added to cells at 2.5 ng ml −1 for 4 h before collection. 2′3′ -cGAMP (InvivoGen) was added to the cells at a concentration of 10 μ g ml −1 for 8 h before collection. For nuclease induction, cells were incubated in Shield-1 (1 μ M, Chemipharma) and 4OHT (2 μ M, Sigma), which were added for 5 h before washing twice with PBS and adding back media without drugs to allow recovery. For synchronization experiments, cells were incubated in CDK1i for 16 h then irradiated as necessary. Immediately following irradiation, media was removed, cells were washed twice in PBS and media without CDK1i was added for an appropriate duration. Herring testis DNA (Sigma) was dissolved in water and transfected into cells at the indicated concentrations using JetPrime reagent (Polyplus Transfection) according to the manufacturer's protocols. CRISPR-Cas9 knockout. Lentivirus was produced using lentiCas9-Blast (a gift from F. Zhang, Addgene #52962) 30 according to standard procedures, concentrated and used to infect MCF10A cells as described 29 . Cells were selected in 10 μ g ml −1 blasticidin (Invivogen) for around 1 week and knockouts were created by infecting cells with lentivirus created using lentiGuide-Puro (a gift from F. Zhang, Addgene #52963) 30 followed by selection in 1 μ g ml −1 puromycin (Sigma) for another week. Cells were plated such that single colonies could be isolated after 2 weeks. Clones for NHEJ knockouts were selected by immunofluorescence staining of 53BP1 24 h after 2 Gy to determine cells with elevated DSB levels. Knockout clones of cGAS and STING were determined by western blotting and multiple clones were pooled for each single-guide RNA (sgRNA). sgRNA sequences are presented in Supplementary Table 1. B16-F10 STING-knockouts were generated as previously described 25 , sgRNA sequences are presented in Supplementary Table 1 . Single-cell clones were screened for knockout by adding cGAMP as described below and monitoring ISG induction. Four confirmed knockouts from each guide were combined together to create the B16-F10 STING-knockout cell line. Western blotting. Western blotting was performed using standard methods. In brief, cells were scraped in PBS and lysed in RIPA buffer (150 mM NaCl, 1% NP-40 alternative, 0.5% sodium deoxycholate, 0.1% SDS, 40 mM Tris pH 8.0) with 1 mM benzamidine HCl, 1 μ g ml −1 antipain, 5 μ g ml −1 aprotinin, 1 μ g ml −1 leupeptin, 1 mM phenylmethansulfonyl fluoride, 10 mM NaF, 2 mM imidazole, 1.15 mM sodium molybdate, 4 mM sodium tartrate and 2 mM sodium orthovanadate (Sigma) for 20 min on ice and cleared by centrifugation. Protein was quantified using Bradford reagent and 20-30 μ g of protein were run per lane of 4-12% Bis-Tris gels (Thermo Fisher Scientific) using either MOPS or MES buffer. Protein was transferred to nitrocellulose membrane at 350 mA for 2 h in transfer buffer (15% methanol, 191 mM glycine, 25 mM Tris-base, 0.1% SDS, pH 8.3). Membranes were blocked in 5% non-fat milk powder in PBS + 0.2% Tween 20 (PBST) and incubated overnight at 4 °C in primary antibody diluted in blocking solution. Primary antibodies are listed in Supplementary Table 2 . After extensive washing in PBST, blots were incubated for 1 h at room temperature in Licor blocking solution (1:1 with PBST) containing IRDye 800CWDonkey anti-rabbit or IRDye 680LT donkey anti-mouse secondary antibody (1:10,000, Licor) as required. Blots were scanned on a Licor Odyssey scanner at a medium resolution setting and exported to ImageJ (NIH). RT-qPCR. RNA was isolated using TRIZOL under standard conditions. Reverse transcription and quantitative PCR was carried out as previously described 29 . Primers are listed in Supplementary Table 3 . Immunofluorescence. Cells were seeded onto coverslips and following treatment were processed as described 29 with the following exceptions. Coverslips were mounted in Vectashield Hard Set mountant containing DAPI (Vector Labs). For pIRF3 staining Tween 20 was omitted from all buffers. Images were captured using a Coolsnap Myo camera (Photometrics) connected to a Nikon Eclips 80i microscope using a 60× oil immersion or 20× air objective and Nikon NIS-Elements software. Images were prepared for publication using FIJI (NIH) and all channels of a given figure were adjusted equivalently only for brightness and contrast. Antibodies are listed in Supplementary Table 2 . Micronucleated cells were classified manually by distinct staining by DAPI of structures outside of the main nucleus. To enumerate cGAS-positive micronuclei these structures were counted manually for each field and expressed as a percentage of total cells within the field. Total nuclear intensity was calculated on a per cell basis using FIJI (NIH). Graphs and statistics were prepared using Prism Graphpad. Flow cytometry. Cells were collected from a single well of a six-well plate using trypsin and washed 1× in PBS before fixation with drop-wise addition of ice-cold 70% ethanol. After fixation on ice (or storage at − 20 °C) cells were washed 1× in PBS and permeabilized in 0.25% Triton X-100/PBS solution on ice for 15 min. Cells were washed 1× in PBS and resuspended in 1% bovine serum albumin/ PBS solution containing 1 μ l per sample of pH3 (serine 10) antibody conjugated to Alexa Fluor 488 (DC28, Cell Signaling). After washing 1× in PBS cells were resuspended in a solution of PBS containing 50 μ g ml −1 propidium iodide (Santa Cruz Biotechnology) and 100 μ g ml −1 RNase A (Roche). Flow cytometry was performed on a FACSCalibur (BD Biosciences) and analysed using FlowJo software. Single cells and G1/S/G2 peaks were manually gated. The gates for pH3-positive cells were chosen by comparison to a population in which the antibody was omitted during processing. Plasmid construction. The plasmid backbone was isolated from pLVX-pTUNER-N using Q5 polymerase and primers (5′-ggatccGGTATTTAAA TAGATCCTCTAGTAGAGTCGGTGTC-3′, 5′-accggtgcggccgcCGATC CCGCCCCTCTCCC-3′) for Gibson assembly. The mCherry fragement was isolated from the pHFUW-mCherry-TRF-FOKI plasmid 31 with Q5 polymerase and primers (5′-agaggatctatttaaataccggatccATGGTGAGCAAGGGCGAG-3′ , 5′-ccatcttcatctcgagCTTGTACAGCTCGTCCATGC-3′). These two fragments were joined by Gibson assembly (New England Biolabs) and digested with XhoI/NotI (New England Biolabs). cGAS was amplified by PCR from Human Lung Fibroblast DNA (Biosettia) using primers: 5′-catctcgagATGCAGCCTTGGCACGGAAAG-3′ and 5′-atggcggccgcTCAAAATTCATCAAAAACTGGAAACTCATTGTTTC-3′ . After digestion with XhoI/NotI the fragment was inserted using a Quick Ligation Kit (New England Biolabs). MCF10A cells were infected with virus as described above.
Live-cell microscopy. The pBABE-H2B-GFP plasmid was a gift from F. Dick (Addgene plasmid #26790) 32 and retrovirus was created using standard protocols and introduced into MCF10A cells expressing mCherry-cGAS. Dual mCherry/ GFP-positive cells were isolated by cell sorting and seeded onto 35 mm Mattek dishes (Mattek). Cells were synchronized with CDK1i and released according to the procedure described above. Imaging was started immediately after release. Imaging was carried out with a Deltavision microscope enclosed in a 37 °C humidified chamber equilibrated with 5% CO 2 . Images were captured using a Photometrics CoolSnapHQ camera using a 40× air objective. Single plane images were acquired every 15 min for 20-24 h. Focus was stable throughout with minor manual adjustments over the imaging time-course. This procedure was repeated three times during which around 100 daughter nuclei could be analysed, corresponding to 50 mitotic events. The mobility of the cells limited the ability to follow all mitotic events to completion. H2B-GFP bodies separate from the main nuclei were identified as micronuclei and apoptotic cells were identified by rapid and severe H2B-GFP condensation before complete dissociation and loss from the culture surface ( Supplementary Video 2) . Senescence-associated β-galactosidase assay. Cells were seeded at around 2 × 10 5 cells per well of a six-well plate, treated 24 h after seeding with ionizing radiation and the indicated agents, and 6 days later were fixed and stained for SA-β Gal as described 33 . Three technical replicates were performed within at least two independent biological experiments.
Conditioned media experiments. Cells for all treatments were plated at a constant density and irradiated as described. Conditioned media was obtained by changing to fresh media 24 h before collection and filtering through a 0.22 μ m filter. This conditioned media was transferred to naive cells and protein lysates for western blotting were collected 24 h later. RNA FISH. RNA FISH was performed as described with modifications 29 . Cells were fixed on coverslips with 2% formaldehyde in PBS and permeabilized at least 24 h and up to 1 week at 4 °C in 70% ethanol. After a brief rinse in RNA Wash buffer (10% formamide/2× SSC), cells were inverted into hybridization buffer containing Custom Stellaris FISH Probes designed against ISG54 (NM_001547) by using the Stellaris RNA FISH Probe Designer (Biosearch Technologies, Inc.) available online at http://www.biosearchtech.com/stellarisdesigner. After overnight hybridization cells were washed twice for 30 min at room temperature in RNA wash buffer, once for 2 min in 2× SSC and mounted in Vectashield. Imaging was performed using a 60× objective as described above. Using ImageJ, all images from a given treatment were combined in a montage and background subtracted with a rolling ball radius of 10. A threshold was chosen based on HT-DNA transfected cells to eliminate any remaining background that was not a clear diffraction limited RNA FISH spot. Cells with at least 10 FISH spots were counted as positive for ISG54. P values to compare between treatments were computed using Graphpad, using a one-way ANOVA with a Bonferroni correction. To compare ISG54 + normal versus micronucleated cells within the treatment group a paired t-test was used. IFNβ-GFP reporter assay. The IFNβ − luciferase reporter plasmid was a gift of R. Vance 34 . Using Gibson assembly the luciferase reporter gene was swapped with eGFP (from pBABE-H2B described above) to form the IFNβ -GFP cassette. A fragment derived from the pLKO.1-Hygro plasmid (a gift from B. Weinberg, Addgene #24150) that omitted the U6 promoter sequence was combined with the IFNβ -GFP cassette to generate the pLKO.1-hygro-IFNβ -GFP reporter. A stable MCF10A cell line was derived as described above by viral infection and selection with 100 μ g ml −1 hygromycin (Invivogen). Activation of GFP was monitored by microcopy in fixed cells. The threshold used for quantification of GFP-positive cells was kept constant throughout all experiments. P values were calculated using Graphpad using a one-way ANOVA with a Bonferroni correction. Transwell migration. For migration through Transwells (Corning Inc.), cells were seeded at 300,000 cells cm −2 onto the topside of the filter membrane and left to migrate in normal culture condition for either 9 or 24 h. For experiments involved CDK1i, cells were exposed to 9 μ M CDK1i and DMSO for 1 h before the seeding onto Transwells. Transwell membrane was fixed in 4% formaldehyde (Sigma) for 15 min, followed by permeabilization by 0.25% Triton X-100 (Sigma) for 10 min, blocked by 5% BSA (Sigma) and overnight incubation in various primary antibodies: lamin-A/C (Santa Cruz), lamin-B (Santa Cruz) and cGAS (Cell Signalling). Finally, the primary antibodies were tagged with the corresponding secondary antibodies for 1.5 h (ThermoFisher). DNA was stained with 8 μ M Hoechst 33342 (ThermoFisher) for 15 min. Confocal imaging was performed on a Leica TCS SP8 system using a 63× /1.4 NA oil-immersion lens. Modified RadVax procedure. Five-to seven-week-old female C57BL/6 mice were obtained from Charles River and maintained under pathogen-free conditions. Mice were divided randomly into cages upon arrival and were randomly injected and measured without blinding. All animal experiments were performed according to protocols approved by the Institute of Animal Care and Use Committee of the University of Pennsylvania (IACUC). The minimal number of animals was used based on prior experience to yield consistent measurements. On the day before the experiment was to begin B16-F10 cells were treated as necessary in vitro with 10 Gy of ionizing radiation with or without CDK1i. As necessary the CDK1i was added 1h before irradiation and maintained until cell isolation and injection on day 2. On day 0 untreated B16-F10 cells (5 × 10 4 ) in 50 μ l of PBS were mixed with an equal volume of Matrigel (BD Biosciences) and injected into the right flank. On day 2, 5 × 10 5 B16-F10 parental or STING-knockout cells treated as described above were mixed with Matrigel and injected on the opposite flank. On days 5, 8 and 11 anti-CTLA4 antibody (9H10; BioXCell) was administered interperitoneally at 200 μ g per mouse. Volumes were measured using calipers starting at day 11 and calculated using the formula l × w 2 × 0.52, where l is the longest dimension and w is perpendicular to l. Animals were killed when either tumour reached 1.5 cm in the largest dimension according to IACUC guidelines. Overall survival and flow cytometry for tumour infiltrating CD8 + T cells was performed as described 25 . For the in situ irradiation experiments of Extended Data Fig. 4e , f experiments were performed using the Small Animal Radiation Research Platform (SAARP) as previously described 24 . Data availability. The authors declare that the data that support the findings of this study are available within the article and Supplementary Information. 

Extended Data Figure 4 | cGAS dynamically relocalizes to micronuclei following mitosis, during migration and after Aurora B inhibition. a, Cells in Fig. 2e were analysed for the fraction of cGAS-positive micronuclei following release from CDK1i. Error bars represent s.e.m. of three biological replicates. b, mCherry-cGAS-expressing cells were monitored by immunofluorescence following 10 Gy. Arrowhead indicates mCherry-cGAS-positive micronucleus (representative of three independent experiments). c, Histogram represents the fraction of daughter cells with cGAS-positive micronuclei or that underwent apoptosis during live-cell imaging. All non-apoptotic daughter cells were micronucleated after division. Error bars are s.e.m. of three biological replicates (n = 99 total daughters). d, Schematic of nuclear migration transwell system. Blue, DAPI; green, lamin A; red, lamin B. cGAS is shown in grayscale. e, Quantification of aberrant nuclei (nuclear blebs and micronuclei) that are cGAS-positive in the transwell migration assay. f, Immunofluorescent staining in an untreated and two representative cells after six-day treatment with Aurora B kinase inhibition (AuroraBi). Scale bar is 10 μ m and similar patterns were observed in two independent experiments. g, Representative (n = 3) western blot of STAT1 activation in non-irradiated cells treated with Aurora B inhibitor for 3 or 6 days. Corresponding author(s): Roger A. Greenberg
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Experimental design 1. Sample size
Describe how sample size was determined. Sample sizes were selected based on previous experience to obtain statistical significance and reproducibility.
Data exclusions
Describe any data exclusions.
For abscopal experiments, mice would be excluded if tumors ulcerated at <1cm in the largest dimensions. This is in agreement with our mouse protocol for humane treatment of mice in tumor studies.
Replication
Describe whether the experimental findings were reliably reproduced.
All experimental data was reliably reproduced in multiple independent experiments as indicated throughout the manuscript
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
For all animal studies, Mice were divided randomly into cages upon arrival and are randomly injected and measured. This procedure is described in detail in the Methods Section.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
The investigators were not blinded during data collection and analysis Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
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